It's been two years since the FDA passed its social media guidance for pharmaceutical advertising in limited-character formats -- that is, primarily, Twitter and Google sponsored links. Among other things, that guidance stipulated that, if a company wants to tweet about the benefit of a drug, they must include the "most serious risks" of that drug in the same tweet and that tweets must contain...
The FDA has, at long last, released draft guidance for how pharmaceutical companies should behave on limited-character social media platforms like Twitter and when correcting misinformation on third-party sites.
The FDA carefully controls labeling, advertisement, and promotion for drugs and devices requiring FDA clearance. It makes sure that companies never list the benefits of a drug without...
